Loading...
Aimei Health Technology Co Ltd (AFJK) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks clear positive catalysts, has weak financial performance, and no significant trading signals or trends. It is better to hold off on investing until more favorable conditions arise.
The MACD histogram is negative (-1.229) and contracting, indicating bearish momentum. RSI is neutral at 35.243, and moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 47.564), with resistance at R1: 55.892.
NULL identified. No recent news or significant insider/hedge fund activity.
is down 1.54%.
In Q3 2025, revenue remained flat at 0 with no YoY growth. Net income dropped significantly by 52.65% YoY to 352,019, and EPS decreased by 25.00% YoY to 0.06. Gross margin also showed no growth.
No analyst ratings or price target changes available.
